Literature DB >> 4511952

Immunity to influenza in ferrets. V. Immunization with inactivated virus in adjuvant 65.

C W Potter, C McLaren, S L Shore.   

Abstract

Ferrets infected with influenza virus A2/Hong Kong/3/68 responded with a febrile reaction; the temperature was elevated by 1.0 degrees C. or greater to a level of 40 degrees C. or more. In addition, relatively high titres of virus were recovered from nasal washings taken 3 days after virus infection, serum antibody was produced, increased nasal protein was detected and nasal washings contained both HI and neutralizing antibody. Of four ferrets immunized with 400 CCA units of inactivated influenza virus A2/Aichi/2/68 in saline, only one produced detectable serum HI antibody, and none produced detectable nasal antibody. These ferrets were subsequently found to be susceptible to intranasal infection with influenza virus A2/Hong Kong/3/68. Thus, the temperature response, the titre of virus recovered from nasal washings and the serum HI antibody response found after virus infection was similar to that found after infection of non-immunized ferrets. However, the increase in protein concentration and the titre of HI and neutralizing antibody found in nasal washings after virus infection was detectably less than that found after virus infection of non-immunized ferrets.Four ferrets were immunized with 400 CCA units of inactivated A2/Aichi/2/68 virus in adjuvant 65, and these ferrets produced relatively high titres of serum HI antibody but no detectable nasal antibody. After subsequent virus infection with influenza virus A2/Hong Kong/3/68, these ferrets showed a modified temperature response, reduced titres of virus in nasal washings compared to that found in nasal washings from non-immunized ferrets, no increase in nasal protein and no detectable nasal HI antibody. Thus, immunization with inactivated virus in adjuvant 65 resulted in a significant modification of the response of ferrets to challenge virus; however, the immunity was not complete, and appreciably less than that found after infection with live homologous virus.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4511952      PMCID: PMC2130445          DOI: 10.1017/s0022172400046258

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  8 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Immunity to influenza in ferrets. II. Influence of adjuvants on immunization.

Authors:  C W Potter; S L Shore; C McLaren; C Stuart-Harris
Journal:  Br J Exp Pathol       Date:  1972-04

3.  Response of ferrets and monkeys to intranasal infection with human, equine and avian influenza viruses.

Authors:  P Marois; A Boudreault; E DiFranco; V Pavilanis
Journal:  Can J Comp Med       Date:  1971-01

4.  New metabolizable immunologic adjuvant for human use. IX. Large-scale trials with multiple lots in different regimens.

Authors:  J Stokes; R E Weibel; A F Woodhour; W J McAleer; L A Potkonski; M R Hilleman
Journal:  JAMA       Date:  1969-03-17       Impact factor: 56.272

5.  Immunity to influenza in ferrets. I. Response to live and killed virus.

Authors:  C W Potter; J S Oxford; S L Shore; C McLaren; C Stuart-Harris
Journal:  Br J Exp Pathol       Date:  1972-04

6.  Antibody response in man to Hong Kong influenza following 1967 formula influenza vaccine in adjuvant 65.

Authors:  A F Woodhour; W J McAleer; A Friedman; R E Weibel; J Stokes; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1969-06

7.  The clinical application of adjuvant 65.

Authors:  M R Hilleman; A Woodhour; A Friedman; R E Weibel; J Stokes
Journal:  Ann Allergy       Date:  1972-03

8.  New metabolizable immunologic adjuvant for human use. 5. Evaluation of highly purified influenza-virus vaccine in adjuvant 65.

Authors:  R E Weibel; A F Woodhour; J Stokes; D P Metzgar; M R Hilleman
Journal:  N Engl J Med       Date:  1967-01-12       Impact factor: 91.245

  8 in total
  9 in total

1.  Immunity to influenza in ferrets. VI. Immunization with adjuvanted vaccines.

Authors:  C W Potter; R Jennings; C McLaren
Journal:  Arch Gesamte Virusforsch       Date:  1973

2.  Immunity to influenza in ferrets. X. Intranasal immunization of ferrets with inactivated influenza A virus vaccines.

Authors:  C McLaren; C W Potter; R Jennings
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

3.  Immunity to influenza in ferrets. VII. Effect of previous infection with heterotypic and heterologous influenza viruses on the response of ferrets to inactivated influenza virus vaccines.

Authors:  C McLaren; C W Potter
Journal:  J Hyg (Lond)       Date:  1974-02

4.  Immunity to influenza in ferrets. XII. Immunization of ferrets with TNBP-split influenza virus vaccine.

Authors:  C McLaren; C W Potter; R Jennings
Journal:  Arch Gesamte Virusforsch       Date:  1974

5.  Immunity to influenza in ferrets. XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization.

Authors:  C McLaren; C W Potter; R Jennings
Journal:  J Hyg (Lond)       Date:  1974-12

6.  Immunity to influenza in ferrets. XIV: Comparative immunity following infection or immunization with live or inactivated vaccine.

Authors:  R J Fenton; A Clark; C W Potter
Journal:  Br J Exp Pathol       Date:  1981-06

7.  Relationship between haemagglutination inhibition titre and immunity to influenza in ferrets.

Authors:  Paul S Wikramaratna; Andrew Rambaut
Journal:  Vaccine       Date:  2015-09-03       Impact factor: 3.641

8.  A plant-produced influenza subunit vaccine protects ferrets against virus challenge.

Authors:  Vadim Mett; Konstantin Musiychuk; Hong Bi; Christine E Farrance; April Horsey; Natalia Ugulava; Yoko Shoji; Patricia de la Rosa; Gene A Palmer; Shailaja Rabindran; Stephen J Streatfield; Alison Boyers; Michael Russell; Alex Mann; Robert Lambkin; John S Oxford; Geoffrey C Schild; Vidadi Yusibov
Journal:  Influenza Other Respir Viruses       Date:  2008-01       Impact factor: 4.380

9.  Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk.

Authors:  Danuta M Skowronski; Marie-Eve Hamelin; Gaston De Serres; Naveed Z Janjua; Guiyun Li; Suzana Sabaiduc; Xavier Bouhy; Christian Couture; Anders Leung; Darwyn Kobasa; Carissa Embury-Hyatt; Erwin de Bruin; Robert Balshaw; Sophie Lavigne; Martin Petric; Marion Koopmans; Guy Boivin
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.